New book by Larry Connors Click here Improve your trading - See how
visit our site at either http://bullinadvantage.com/ or http://redhotpennystock.com/ to sign up for our free ahead of the curve newsletter! _____________________________________________________________________
PanGenex Corporation (Pink Sheets: PGXC - http://finance.yahoo.com/q?s=PGXC.ob)
June 23rd, 2008-- In support of its ever growing line of unique, natural, nutraceutical products, PanGenex Corporation (Pink Sheets: PGXC - News) announces the launch of a new retail and physician web platform at www.HeartHealthyWorld.com. This announcement follows the June 6, 2008 introduction of its highly regarded, all-natural LIPIDEME(TM) product which is the first product on the market to combine the triglyceride-lowering power of Omega-3 fatty acids with the cholesterol lowering ability of plant sterols (phytosterols) and tocotrienols (part of the Vitamin E family) and the enzyme CoQ10.
www.HeartHealthyWorld.com has global capacity and creates a seamless link from a physician's office and retailer outlets to PanGenex fulfillment and research centers as well as featuring the complete PanGenex product line in an easy to navigate format. The platform has an additional component which allows consumers to purchase product, research formulations and learn more about living a "Heart Healthy" lifestyle.
According to the Nutrition Business Journal's "Supplement Business Report", sales of over-the-counter nutraceuticals exceeded $68B in 2007 with an expected increase of over 3 percent in 2008.
"End user connectivity, whether in providing product information or in order processing, is a key tenant of consumer marketing. PanGenex has invested significant capital in developing tools that will spread the word about our superior, pharmaceutical grade products and at the same time make it simple and fast for interested parties to purchase PanGenex products worldwide," states Jeff Roman, President and CEO of PanGenex Corporation.
* The statements in this press release have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Visit HeartHealthyWorld.com at:
www.HeartHealthyWorld.com
About PanGenex Corporation:
PanGenex is a publicly traded corporation (PINK SHEETS: PGXC | Quote | Chart | News | PowerRating) and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners throughout the, retail establishments and the internet on websites such as www.PanGenex.com and www.HeartHealthyWorld.com.
Welwind Energy International Corp (the "Company") (OTCBB: WWEI - http://finance.yahoo.com/q?s=WWEI.ob)
June 23rd, 2008-- Welwind Energy International Corp. (OTCBB:WWEI) (the "Company") is pleased to announce that it is entering into a land lease agreement in the Peace River Region of British Columbia, Canada. The Peace River Region has been deemed as an exceptional location to develop a wind farm with multiple projects currently being perused. In a November 6, 2007 news release the company announced that it had sent a representative to survey the land, and data results for build out were favorable. After visiting the site at Tumbler Ridge British Columbia, Canada, it was determined that the site is an excellent location to proceed with a wind farm project.
Initially it was announced that the company would be pursuing approximately 13 quarter sections (approximately 2300 acres) of privately owned farmer's field property. After multiple meetings, the company is now looking at doubling its land position to 4680 acres (28 quarter sections). The company anticipates acquiring additional private land and/or crown land around the existing 4680 acres in the near future. Depending on the size of the turbines installed, the company will be looking at generating a minimum of 100 MW.
This location has an excellent set of roads for accessing the potential site. The site presents virtually no encumbrances to an installation of either a meteorological tower or a wind farm. Road access for turbine installation would also be ideal as the road runs adjacent to the site.
Additional information on the company and its projects can be found on the company website and will be given at the company's investor conference call later today at 1:00 p.m. PDT.
"According to past studies, the Peace Region is known to have the best wind speeds in BC. Today's news allows the company to diversify its portfolio and we are pleased to include Canada in our business model. BC Hydro's wind call has created Canada's next gold rush boom," says Shannon de Delley, Director of Welwind.
ABOUT PEACE REGION AND BC HYDRO
British Columbia (BC) is about to enter a new era of clean energy generation with the largest clean power call ever issued in the province, setting the stage for BC's untapped potential of wind energy to be realized. BC Hydro is asking power producers to submit proposals that collectively will add up to 5,000 gigawatt hours (GWh) of clean or renewable energy per year, enough to power 500,000 homes.
With over 5,000 MW of potential generating capacity in the province, Welwind is in a perfect position to be part of the province's alternative energy gold rush. 1,600 MW of wind energy capacity would represent close to $4 Billion in investment and would create 3,000 jobs throughout the province, placing BC amongst the leaders in wind energy generation in Canada.
The Clean Power Call RFP aligns with the BC Energy Plan: A Vision for Clean Energy Leadership (http://energyplan.gov.bc.ca/), released February 27, 2007, which indicates that at least 90 per cent of all electricity generated in the province must continue to come from clean or renewable sources and to achieve electricity self-sufficiency by 2016.
Quest Minerals & Mining Corp. (OTCBB:QMNM - http://finance.yahoo.com/q?s=QMNM.ob)
June 20th, 2008-- Quest Minerals & Mining Corp. (OTCBB:QMNM) (Frankfurt:QMNB), a Kentucky based operator of energy and mineral related properties, announced today that it is diligently working to conclude their final stages of rehabilitation so that they can move into full production. The company is currently preparing to mine its Pond Creek location, held under its wholly owned subsidiary, Gwenco, Inc.
Eugene J. Chiaramonte, Jr., President of Quest Minerals and Mining Corp., stated, " I have spent many hours underground to ensure that we are mining as soon as possible. Despite some minor encounters related to equipment delays, our long awaited production phase is imminent. Pending any unaccountable obstacles, we expect to be ready for production within a week to two weeks. The company is eager to launch its $8 million contract fulfillment with Logan & Kanawha Co., LLC. We will provide continual updates as production incurs."
About Quest Minerals & Mining
Quest Minerals & Mining Corp., or Quest, acquires and operates energy and mineral related properties in the southeastern part of the United States. Quest focuses its efforts on properties that produce quality compliance blend coal. For more information on Quest Minerals & Mining Corp., please visit our website at www.questmining.net.
BIH Corporation (PINKSHEETS: BIHC - http://finance.yahoo.com/q?s=bihc.pk)
June 23rd, 2008-- BIH Corporation (PINKSHEETS: BIHC | Quote | Chart | News | PowerRating) announced today that its Board of Directors including Mr. Cris Galo, President, held a strategy meeting this weekend regarding a previously announced offer regarding BIHC stock. BIH Corporations Board has determined that the best course of action was to have its corporate counsel engage in dialog with the private investor/groups offer through their counsel to determine exactly what they are attempting to achieve. The objective has been identified; the unsolicited offer by the private investor/group is an interest in BIH Corporation's subsidiary Baron International, and the investors have indicated that they would like to play a role through either a large investment position or even a complete buyout.
"Regardless of whatever direction the company elects, all decisions will consider the best interest of The Company and its Shareholders as this will be paramount to any deal; negotiations are ongoing at a rapid pace and the company will update all pertinent information as it develops," said Frank Nordstrom, company spokesman.
i2Telecom International, Inc. ("i2Telecom(R)") (OTCBB: ITUI - http://finance.yahoo.com/q?s=ITUI.ob)
June 23rd, 2008-- i2Telecom International, Inc. ("i2Telecom(R)") (OTCBB: ITUI), a developer of award-winning patented and innovative high-quality Voice-over-Internet Protocol ("VoIP") products and services, today announced that it expects revenues from the sale of VOIP products and related services to exceed $5 million in the year ending December 31, 2008, compared with less than $1 million in revenues during 2007.
This anticipated revenue growth will be driven by revenue-sharing and licensing agreements involving the Company's new MyGlobalTalk(TM) technology. In addition, the Company may have the opportunity to realize further profits from the monetization of a portion of its growing intellectual property portfolio. The Company currently has patent applications pending related to over a dozen different additional important VoIP technologies, all of which are deployed today in the Company's VoIP technology offerings.
The Company attributes much of the anticipated acceleration in revenue growth to its new patent-pending MyGlobalTalk(TM) technology, which has been met with great enthusiasm among current and prospective customers.
-- MyGlobalTalk(TM) is an innovative, unique and proprietary software application developed internally by i2Telecom's R&D team.
-- MyGlobalTalk(TM) places Internet telephony in the hands of every cellular phone user, independent of wireless carrier technology, handset manufacturer, or the type of wireless carrier voice/data plan involved.
-- Once MyGlobalTalk(TM) is installed on a cellular handset, users are able to call any telephone in the world directly from their cellular phones using VoIP technology, at a fraction of normal long-distance rates.
-- MyGlobalTalk(TM) utilizes a prepaid, "pay as you go" plan structure and no long-term contract is required.
-- Additionally, MyGlobalTalk(TM) is fully functional without requiring local access to the Internet or proximity to an Internet "hotspot."
-- MyGlobalTalk(TM) users also need not wait for the availability of dual-mode WiFi phones, because MyGlobalTalk(TM) provides the benefits of dual-mode phones at a fraction of the cost, using customers' existing mobile handsets.
-- MyGlobalTalk(TM) does not require carriers to participate, since users can sign-up independently for the service.
"Market response to MyGlobalTalk(TM) has been tremendous, and we anticipate adding a significant number of new customers in the near future," commented Paul Arena, Chief Executive Officer of i2Telecom International, Inc. "The explosive growth in wireless service, with approximately 2.6 billion GSM users worldwide and approximately 220 million cellular users in the United States alone, has greatly expanded the opportunities to access Mobile VoIP technology. MyGlobalTalk(TM) allows users to conveniently make low-cost long distance calls from their cell phones to anywhere in the world."
MyGlobalTalk(TM) has recently received a number of awards, including the 2007 INTERNET TELEPHONY(R) Magazine's 'Product of the Year' Award, the 'Best of Show' Award at the IT Expo East 2008, the 2007 'Product of the Year' Award by Unified Communications Magazine, and the 2007 'Product of the Year' Award by Communications Magazine. MyGlobalTalk(TM) was also the subject of this month's cover story in the leading industry trade journal INTERNET TELEPHONY Magazine.
"The addition of MyGlobalTalk(TM) to our family of proprietary VoIP technology solutions will allow i2Telecom to deliver a unique, low-cost telephony service to businesses and consumers by combining the benefits of unparalleled mobility with VoIP technology," continued Arena. "MyGlobalTalk(TM) is the first VoIP service of its kind and provides higher-level user functionality to wireless users. The VoIP market is transitioning from an 'early adopter' phase into a practical, dependable service offering that meets the telephony requirements of a much broader market, and we believe i2Telecom will emerge as one of the leading independent software development companies in the industry. We believe ongoing changes within the telecom industry will continue to reward innovative and nimble companies." "Our channel distribution response to MyGlobalTalk(TM) has been very enthusiastic, and negotiations on a number of revenue-sharing and licensing agreements are underway. Based upon contracts and initiatives that are already in place, we expect i2Telecom's revenues to approach $2 million in the third quarter of 2008, or more than double the Company's revenues for the entire year ended December 31, 2007. Revenues should approximate $3 million in the fourth quarter, resulting in full-year 2008 revenues in excess of $5 million," concluded Arena.
About i2Telecom International, Inc.
i2Telecom International, Inc. is a developer of award-winning patented and innovative high-quality Voice-over-Internet Protocol ("VoIP") products and services that employ best-of-breed VoIP technology and use a combination of the Company's own services network and the Internet to deliver high-quality phone calls, streaming video and text chat to customers on a global scale. i2Telecom International provides its VoiceStick(R), MyGlobalTalk(TM), Digital Portal communications and microgateway adapters for VoIP long-distance and other enhanced communication services to its subscribers. Its patent pending services technology platform is compliant with the Session Initiation Protocol ("SIP") telecommunications industry standard. For additional information visit www.i2telecom.com or www.voicestick.com or www.myglobaltalk.com or call 404-567-4750.
Oncolin Therapeutics, Inc., (OTCBB:OCOL - http://finance.yahoo.com/q?s=OCOL.ob)
June 23rd, 2008-- Oncolin Therapeutics, Inc., (OTCBB:OCOL) is very pleased to announce that Dr. Daniel Von Hoff has joined the company's Scientific Advisory Board (SAB). Dr. Von Hoff is generally considered to be one of the world's leading experts in oncology drug development and is an advisor in some capacity to a large number of oncology companies.
Dr. Von Hoff was appointed to President Bush's National Cancer Advisory Board in June 2004. Dr. Von Hoff is the past President of the American Association for Cancer Research (the world's largest cancer research organization), a Fellow of the American College of Physicians, and a member and past board member of the American Society of Clinical Oncology. He is a founder of ILEX(TM) Oncology, Inc. (acquired by Genzyme after Ilex had 2 agents, alemtuzumab and clofarabine approved for patients with leukemia). He is founder and the Editor Emeritus of Investigational New Drugs - The Journal of New Anticancer Agents; and, Editor-in-Chief of Molecular Cancer Therapeutics.
Daniel D. Von Hoff, M.D., is currently Physician in Chief, Senior Investigator and Director of Translational Research at the Translational Genomics Research Institute's (TGen) Translational Drug Development Division and Head, Pancreatic Cancer Research Program in Phoenix, Arizona. He is also Chief Scientific Officer for US Oncology and Chief Scientific Officer, Scottsdale Clinical Research Institute. He has done work on the development of many anticancer agents, including paclitaxel, docetaxel, gemcitabine, camptosar and hab-paclitaxel.
"Oncolin Therapeutics is very excited to have someone with Dr Von Hoff's stature and experience as a member of our SAB. His oncology development experience will be a major addition to our advisory board," said Dr. Donald Picker, COO of Oncolin.
About Oncolin Therapeutics, Inc.
Headquartered in Houston, Texas, Oncolin Therapeutics, Inc. is a publicly traded biopharmaceutical company that engages in the discovery, development and commercialization of novel selective anticancer therapies. Additional information about Oncolin can be found on the web at www.oncolinthera.com.
Visit http://www.redhotpennystock.com to read our full disclaimer and/or sign up for our exceptional newsletter! Bull in Advantage, LLC Legal Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The employees are NOT Registered as Investment Advisors in any jurisdiction whatsoever. Also note that by submitting a request for a page on our website, or by signing up for our Newsletter you are explicitly consenting to have read, understood, and agreed to all of the terms set forth by this disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold Bull in Advantage, LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss(monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. Bull in Advantage, LLC does on occasion sell shares in the open market without notice, ; and on occasion is compensated by a Third-Party for its above-referenced services with the companys stock. Bull in Advantage, LLC reserves its right to sell such securities at any time and without notice. An owner of Bull in Advantage, LLC received thirty seven thousand free trading shares of (PGXC) from a third party as consideration for one week of IR/PR services for (PGXC). On 6.2.08 an owner of Bull in Advantage, LLC received one hundred thousand free trading shares of (OCOL) from a third party as consideration for one month of IR/PR services for (OCOL). The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. Where such errors/omissions occur, the employees will expediently and without fail, correct said errors/omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. Bull in Advantage, LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided, and explicitly consented by the companies profiled, OR is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. However, Bull in Advantage, LCC maintains that it will publish information which is accurate to the best of it's knowlegde. If at any time updated data becomes available, it is the responsibility of the employees to bring you said information in a timely manner. Bull in Advantage, LLC and its affiliates are not registered or liscenced investment advisors, nor broker dealers. Bull in Advantage, LLC advises that the investments in companies profiled are commonly considered to be high risk and use of the information provided is at the investor's sole risk. Bull in Advantage, LLC also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should never rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Bull in Advantage, LLC makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through our services. Employees/Officers may or may not hold positions in the companies that are profiled. The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results. Third Party Web Sites and Information: The Bull in Advantage website and newsletter may provide hyperlinks to third party websites or access to third party content. Note that Bull in Advantage, LLC does not provide, control, endorse, or guarantee content found in such sites, except where clearly listed as having done so. (As in the case of a widespread Press-Release) You agree that Bull in Advantage, LLC is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that Bull in Advantage, LLC shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
